BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 35369296)

  • 1. Cardio-Oncology: A Myriad of Relationships Between Cardiovascular Disease and Cancer.
    Wang Y; Wang Y; Han X; Sun J; Li C; Adhikari BK; Zhang J; Miao X; Chen Z
    Front Cardiovasc Med; 2022; 9():727487. PubMed ID: 35369296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer and cardiovascular disease: can understanding the mechanisms of cardiovascular injury guide us to optimise care in cancer survivors?
    Truong LL; Scott L; Pal RS; Jalink M; Gunasekara S; Wijeratne DT
    Ecancermedicalscience; 2022; 16():1430. PubMed ID: 36158986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greenspace, Inflammation, Cardiovascular Health, and Cancer: A Review and Conceptual Framework for Greenspace in Cardio-Oncology Research.
    Bikomeye JC; Beyer AM; Kwarteng JL; Beyer KMM
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CVD phenotyping in oncologic disorders: cardio-miRNAs as a potential target to improve individual outcomes in revers cardio-oncology.
    Yang M; Li T; Guo S; Song K; Gong C; Huang N; Pang D; Xiao H
    J Transl Med; 2024 Jan; 22(1):50. PubMed ID: 38216965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Risk in Cancer Survivors.
    Agmon Nardi I; Iakobishvili Z
    Curr Treat Options Cardiovasc Med; 2018 Apr; 20(6):47. PubMed ID: 29705862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardio-Oncology rehabilitation- challenges and opportunities to improve cardiovascular outcomes in cancer patients and survivors.
    Sase K; Kida K; Furukawa Y
    J Cardiol; 2020 Dec; 76(6):559-567. PubMed ID: 32736905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular complications of cancers and anti-cancer therapy].
    Vyskočil J; Petráková K; Jelínek P; Furdek M
    Vnitr Lek; 2017; 63(3):200-209. PubMed ID: 28379023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary prevention and management strategies for colorectal cancer and cardiovascular disease.
    Whelton SP; Berning P; Blumenthal RS; Marshall CH; Martin SS; Mortensen MB; Blaha MJ; Dzaye O
    Eur J Intern Med; 2021 May; 87():3-12. PubMed ID: 33610416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardio-oncology: where do we stand for in Belgium?
    Lancellotti P; De Pauw M; Claeys M
    Acta Cardiol; 2021 Apr; 76(2):204-208. PubMed ID: 31967938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
    Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
    BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A narrative review on the interaction between genes and the treatment of hypertension and breast cancer.
    Wang W; He Q; Zhang H; Zhuang C; Wang Q; Li C; Sun R; Fan X; Yu J
    Ann Transl Med; 2021 May; 9(10):894. PubMed ID: 34164528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.
    Mehta LS; Watson KE; Barac A; Beckie TM; Bittner V; Cruz-Flores S; Dent S; Kondapalli L; Ky B; Okwuosa T; Piña IL; Volgman AS;
    Circulation; 2018 Feb; 137(8):e30-e66. PubMed ID: 29437116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden and prognostic impact of cardiovascular disease in patients with cancer.
    Raisi-Estabragh Z; Manisty CH; Cheng RK; Lopez Fernandez T; Mamas MA
    Heart; 2023 Nov; 109(24):1819-1826. PubMed ID: 37321830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.
    Parent S; Pituskin E; Paterson DI
    Can J Cardiol; 2016 Jul; 32(7):847-51. PubMed ID: 27343743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceptions of the Cardiologists and Oncologists: Initial Step for Establishing Cardio-Oncology Service.
    Farhan HA; Yaseen IF
    Front Cardiovasc Med; 2021; 8():704029. PubMed ID: 34917654
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular drug interventions in the cardio-oncology clinic by a cardiology pharmacist: ICOP-Pharm study.
    Yaseen IF; Farhan HA
    Front Cardiovasc Med; 2022; 9():972455. PubMed ID: 36247485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of research on the intersection between breast cancer and cardiovascular research in the Women's Health Initiative (WHI).
    Raychaudhuri S; Dieli-Conwright CM; Cheng RK; Barac A; Reding KW; Vasbinder A; Cook KL; Nair V; Desai P; Simon MS
    Front Oncol; 2022; 12():1039246. PubMed ID: 37025252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Importance of Primary Care in Cardio-Oncology.
    Cehic DA; Sverdlov AL; Koczwara B; Emery J; Ngo DTM; Thornton-Benko E
    Curr Treat Options Oncol; 2021 Oct; 22(12):107. PubMed ID: 34674055
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.